P1714: HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS IN EUROPE

• A. Jaccard,
• F. Bridoux,
• W. Roeloffzen,
• M. C. Minnema,
• R. Bergantim,
• R. Hájek,
• C. João,
• M. T. Cibeira,
• G. Palladini,
• S. Schönland,
• G. Merlini,
• P. Milani,
• M. A. Dimopoulos,
• S. Ravichandran,
• U. Hegenbart,
• H. Agis,
• B. Gros,
• A. Asra,
• E. Dergarabetian,
• V. Magarotto,
• A. Leonidakis,
• G. Cheliotis,
• P. Sonneveld,
• A. Wechalekar,
• E. Kastritis

Affiliations

A. Jaccard

1 National Amyloidosis Center and Hematology Unit, CHU Limoges, Limoges

F. Bridoux

2 Nephrology Unit, CHU Poitiers, Poitiers, France

W. Roeloffzen

3 Amyloidosis Centre of Expertise, Department of Internal Medicine, Faculty of Medical Sciences, University Medical Center Groningen, Groningen

M. C. Minnema

4 Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands

R. Bergantim

5 Department of Hematology, Hospital São João, Porto, Portugal

R. Hájek

6 Department of Haematooncology, University Hospital Ostrava, Ostrava, Czechia

C. João

7 Hematology Department, Champalimaud Center for the Unknown, Lisbon, Portugal

M. T. Cibeira

8 Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain

G. Palladini

9 Amyloidosis Research and Treatment Center, Foundation “Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo”, Department of Molecular Medicine, University of Pavia, Pavia, Italy

S. Schönland

10 Medical Department V, Amyloidosis Center Heidelberg, University of Heidelberg, Heidelberg, Germany

G. Merlini

9 Amyloidosis Research and Treatment Center, Foundation “Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo”, Department of Molecular Medicine, University of Pavia, Pavia, Italy

P. Milani

9 Amyloidosis Research and Treatment Center, Foundation “Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo”, Department of Molecular Medicine, University of Pavia, Pavia, Italy

M. A. Dimopoulos

11 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

S. Ravichandran

12 National Amyloidosis Centre, University College London, London, United Kingdom

U. Hegenbart

10 Medical Department V, Amyloidosis Center Heidelberg, University of Heidelberg, Heidelberg, Germany

H. Agis

13 Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University Vienna, Vienna, Austria

B. Gros

14 Janssen-Cilag S.A., Madrid, Spain

A. Asra

15 Janssen-Cilag S.A., London, United Kingdom

E. Dergarabetian

15 Janssen-Cilag S.A., London, United Kingdom

V. Magarotto

16 Janssen-Cilag S.A., Rome, Italy

A. Leonidakis

17 Health Data Specialists, Dublin, Ireland

G. Cheliotis

17 Health Data Specialists, Dublin, Ireland

P. Sonneveld

18 Erasmus MC Cancer Institute, Rotterdam, Netherlands

A. Wechalekar

12 National Amyloidosis Centre, University College London, London, United Kingdom

E. Kastritis

11 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece